Sign in to view content

Brolucizumab: Will it Make a Differance

Andrew P. Schachat, MD

Video
Published 2018

Related

Factors Associated with Worsening Proliferative Diabetic Retinopathy
Carl W. Baker, MD, FASRS
Updates from the Field
2017
A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018
Surveying the Dry AMD Landscape. Is help on the way?
David S. Boyer, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more